Antiviral AgentsVirus ReplicationVirus DiseasesCell LineAcyclovirOrganophosphonatesRimantadineDrug Resistance, ViralAmantadineTrifluridineOseltamivirViral Plaque AssayInterferonsNucleosidesInfluenza, HumanRibavirinZanamivirGanciclovirHepacivirusCytosineVero CellsFoscarnetProdrugsInterferon-alphaHIV-1Cercopithecus aethiopsIdoxuridineCytomegalovirusZalcitabineOrganophosphorus CompoundsRNA, ViralSimplexvirusRibonucleosidesVirusesAdenineInfluenza A Virus, H1N1 Subtype2-AminopurineAnti-HIV AgentsInfluenza B virusInfluenza A virusPost-Exposure ProphylaxisOrthomyxoviridaeHepatitis B virusHerpes SimplexZidovudineLamivudineReverse Transcriptase InhibitorsPyransViral ProteinsInhibitory Concentration 50Cytomegalovirus InfectionsHepatitis B, ChronicViral Nonstructural ProteinsHepatitis C, ChronicHIVHerpesvirus 1, HumanArabinonucleotidesVidarabine PhosphateInterferon Type IMolecular Sequence DataDNA, ViralArabinofuranosyluracilDrug Therapy, CombinationVirus InternalizationDrug Evaluation, PreclinicalVidarabineCytopathogenic Effect, ViralHerpesviridaeHepatitis CViral LoadNeuraminidaseHerpesvirus 2, HumanDrug DesignStructure-Activity RelationshipCells, CulturedEnterovirus A, HumanEye Infections, ViralInterferon-betaHepatitis BDideoxynucleosidesMyxovirus Resistance ProteinsIsoxazolesInfluenza A Virus, H3N2 SubtypeHerpes ZosterInfluenza A Virus, H5N1 SubtypeInfluenza VaccinesRepliconProtease InhibitorsGuanineVirus ActivationVesicular stomatitis Indiana virusAmino Acid SequenceHerpesvirus 3, HumanVaccinia virusHerpesviridae InfectionsMolecular StructureModels, MolecularOrthomyxoviridae InfectionsHeLa CellsRNA Replicase